Stay updated on scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Sign up to get notified when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.

Latest updates to the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page
- Check9 days agoNo Change Detected
- Check11 days agoChange DetectedAdded the MeSH term 'Mucopolysaccharidosis, MPS-III-A' to the study record.SummaryDifference0.0%

- Check18 days agoChange DetectedAdded a screening threshold: Cohorts 1-3 require anti-AAV9 antibody titers ≥ 1:100 (ELISA) to be considered positive. The previous screening criterion for Cohort 4 antibody positivity at screening has been removed.SummaryDifference0.2%

- Check25 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.0%

- Check32 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

- Check61 days agoChange DetectedRevision: v3.4.2 is now displayed, and the previous government funding/operating-status notice has been removed.SummaryDifference0.4%

- Check68 days agoChange DetectedA system notice about government funding lapse and NIH Clinical Center status was added. The site revision updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to scAAV9.U1a.hSGSH Gene Transfer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the scAAV9.U1a.hSGSH Gene Transfer Clinical Trial page.